Actigen™ is a second generation, unique bioactive fraction derived from the outer cell wall of a specific strain of yeast, Saccharomyces cerevisiae, where it acts in the gut to bind pathogenic bacteria, preventing disease and competition for nutrients. In the current trial, 260 sows were used and fed either an unsupplemented control diet or one containing Actigen™ at 0.08% of the formulation during gestation, farrowing and lactation, to assess its impact on sow and piglet performance. Results showed significant increases in feed intake for sows fed Actigen™ pre-farrowing, but this was reversed during lactation, leading to a 7 kg saving in feed intake per animal. At birth, piglets weighed 42 g more in litters from Actigen™-fed sows compared to the control group. Weaning weight of the total litter from Actigen™ sows was significantly higher (P< 0.05) by 3.3 kg, although individual piglet weights were the same. Sows showed no significant loss in body weight during the trial, indicating that the improved piglet production was related to improved nutrient availability and perhaps Ig status of piglets due to the addition of Actigen™ in the diet.

Two experiments were conducted to compare effects of utilising step-down dosing of a mannan-rich fraction (MRF) of yeast cell wall or the antimicrobial growth promoter (AGP) bacitracin methylene disalicylate (BMD) when chicks were raised on built-up litter. Chicks were randomly assigned to one of three treatment groups (12 pen replicates; 50 birds per pen): basal diet (control) or basal diet plus MRF (Actigen™; Alltech Inc., Nicholasville, KY) or BMD (Alpharma Inc., Fort Lee, NJ). In experiment two, intestinal morphology and litter scores were determined on d 42. In experiment one, MRF and BMD increased BW gain at d 21 and d 42 compared with control (P ≤ 0.05) and d 42 BW was greater in BMD birds than controls (P ≤ 0.05). Adjusted FCRs were lower in MRF and BMD birds from d 0 to d 42 (P = 0.06). In experiment two, there was no effect of treatment on d 21 BW, but MRF and BMD improved adjusted FCR (P = 0.02) compared with control. By d 35, both MRF and BMD birds had greater BWs than controls (P = 0.04). At d 42, MRF-supplemented birds had greater BW than controls (P ≤ 0.05). D 35 and d 42 FCR improved with MRF or BMD compared with control (P ≤ 0.01). Litter conditions improved (P ≤ 0.05) when birds were fed diets with BMD and MRF compared with control-fed birds. Jejunal morphology, including villi height (P ≤ 0.05), villi height: crypt depth ratio (P ≤ 0.05), and goblet cell numbers (P ≤ 0.05) improved with MRF and BMD compared with control. Both MRF and BMD improved broiler performance, potentially related to the improvements observed in intestinal morphology. In conclusion, step-down supplementation with MRF may offer a potential alternative to AGP to improve performance in broilers raised in commercial settings.